Cargando…

In vivo treatment of tyrosinaemia with hypercompact Cas12f1

Detalles Bibliográficos
Autores principales:	Guo, Ruochen, Li, Zhifang, Li, Guoling, Zhang, Hainan, Zhang, Chang, Huo, Xiaona, Zhang, Xiaoyin, Yang, Xiali, Yang, Rongrong, Liu, Yuanhua, Sun, Xiaozhi, Liu, Xinyu, Yang, Hui, Zhou, Yingsi, Xu, Chunlong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352374/ https://www.ncbi.nlm.nih.gov/pubmed/37460535 http://dx.doi.org/10.1038/s41421-023-00554-y

Ejemplares similares

Molecular basis for DNA cleavage by the hypercompact Cas12j-SF05
por: Duan, Zhiqiang, et al.
Publicado: (2023)

Hypercompact CRISPR–Cas12j2 (CasΦ) enables genome editing, gene activation, and epigenome editing in plants
por: Liu, Shishi, et al.
Publicado: (2022)

Modulation of metabolic functions through Cas13d-mediated gene knockdown in liver
por: He, Bingbing, et al.
Publicado: (2020)

Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia
por: Pankowicz, Francis P., et al.
Publicado: (2016)

Recommendations for the management of tyrosinaemia type 1
por: de Laet, Corinne, et al.
Publicado: (2013)

Develop a Compact RNA Base Editor by Fusing ADAR with Engineered EcCas6e
por: Wang, Xing, et al.
Publicado: (2023)

Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria
por: Ranganath, L. R., et al.
Publicado: (2022)

UK Dietary Practices for Tyrosinaemias: Time for Change
por: Daly, Anne, et al.
Publicado: (2022)

Diazoxide-responsive hyperinsulinaemic hypoglycaemia in tyrosinaemia type 1
por: Sotiridou, Ellada, et al.
Publicado: (2021)

Efficient CRISPR editing with a hypercompact Cas12f1 and engineered guide RNAs delivered by adeno-associated virus
por: Kim, Do Yon, et al.
Publicado: (2021)

The α isoform of topoisomerase II is required for hypercompaction of mitotic chromosomes in human cells
por: Farr, Christine J., et al.
Publicado: (2014)

Mini-dCas13X–mediated RNA editing restores dystrophin expression in a humanized mouse model of Duchenne muscular dystrophy
por: Li, Guoling, et al.
Publicado: (2023)

Engineered CRISPR-OsCas12f1 and RhCas12f1 with robust activities and expanded target range for genome editing
por: Kong, Xiangfeng, et al.
Publicado: (2023)

Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice
por: Mayorandan, Sebene, et al.
Publicado: (2014)

Natural Protein Tolerance and Metabolic Control in Patients with Hereditary Tyrosinaemia Type 1
por: Yilmaz, Ozlem, et al.
Publicado: (2020)

Hepatorenal Tyrosinaemia: Impact of a Simplified Diet on Metabolic Control and Clinical Outcome
por: Bärhold, Friederike, et al.
Publicado: (2020)

Mitochondrial base editor DdCBE causes substantial DNA off-target editing in nuclear genome of embryos
por: Wei, Yinghui, et al.
Publicado: (2022)

Syndrome of Inappropriate Antidiuretic Hormone Secretion in a Patient with Uncontrolled Tyrosinaemia Type 1
por: Al-Hinai, Abdulhamid, et al.
Publicado: (2021)

Human cleaving embryos enable efficient mitochondrial base-editing with DdCBE
por: Wei, Yinghui, et al.
Publicado: (2022)

Homologous recombination mediates stable Fah gene integration and phenotypic correction in tyrosinaemia mouse-model
por: Junge, Norman, et al.
Publicado: (2018)

Physical Growth of Patients with Hereditary Tyrosinaemia Type I: A Single-Centre Retrospective Study
por: Yilmaz, Ozlem, et al.
Publicado: (2021)

Elimination of Cas9-dependent off-targeting of adenine base editor by using TALE to separately guide deaminase to target sites
por: Liu, Yang, et al.
Publicado: (2022)

Analysis of clinical and imaging features of Behcet's disease-related pulmonary lesions: a series of eight cases
por: Zhang, Bingjie, et al.
Publicado: (2022)

Craspase: A novel CRISPR/Cas dual gene editor
por: Huo, George, et al.
Publicado: (2023)

Cas12a mediates efficient and precise endogenous gene tagging via MITI: microhomology-dependent targeted integrations
por: Li, Pan, et al.
Publicado: (2019)

CRISPR/Cas9-mediated knockout of intracellular molecule SHP-1 enhances tumor-killing ability of CD133-targeted CAR T cells in vitro
por: Liu, Ming, et al.
Publicado: (2023)

hsa_circ_0056856 in the serum serves as a potential novel biomarker for disease activity in psoriasis
por: Zhang, Mingwang, et al.
Publicado: (2022)

A Cas9–transcription factor fusion protein enhances homology-directed repair efficiency
por: Li, Guoling, et al.
Publicado: (2021)

Human 8-cell embryos enable efficient induction of disease-preventive mutations without off-target effect by cytosine base editor
por: Wei, Yinghui, et al.
Publicado: (2022)

Programmable deaminase-free base editors for G-to-Y conversion by engineered glycosylase
por: Tong, Huawei, et al.
Publicado: (2023)

CRISPR-Cas9-mediated editing of the OsHPPD 3′ UTR confers enhanced resistance to HPPD-inhibiting herbicides in rice
por: Wu, Yunyu, et al.
Publicado: (2023)

Identification of prophylaxis and treatment for hospitalized patients associated with venous thromboembolism
por: Yang, Yuanhua, et al.
Publicado: (2023)

Efficient and precise base editing in rabbits using human APOBEC3A-nCas9 fusions
por: Liu, Zhiquan, et al.
Publicado: (2019)

CRISPR-Cas12a-assisted nucleic acid detection
por: Li, Shi-Yuan, et al.
Publicado: (2018)

Small molecules enhance CRISPR/Cas9-mediated homology-directed genome editing in primary cells
por: Li, Guoling, et al.
Publicado: (2017)

CRISPR–Cas12a base editors confer efficient multiplexed genome editing in rice
por: Cheng, Yanhao, et al.
Publicado: (2023)

Response to “Reproducibility of CRISPR-Cas9 methods for generation of conditional mouse alleles: a multi-center evaluation”
por: Yang, Hui, et al.
Publicado: (2021)

Metagenomic discovery of novel CRISPR-Cas13 systems
por: Hu, Yanping, et al.
Publicado: (2022)

Highly efficient and precise base editing by engineered dCas9-guide tRNA adenosine deaminase in rats
por: Ma, Yuanwu, et al.
Publicado: (2018)

Efficient base editing with expanded targeting scope using an engineered Spy-mac Cas9 variant
por: Liu, Zhiquan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_csso65as4jrm1b12fd7a5rnq1v